Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-03-18 00:00:00 ET · period of report 2023-01-09 · accession 0001415889-24-008313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2023-01-09 | MIRM | Peetz Christopher | CEO, Dir | S - Sale | $20.62 | -5,159 | 92.0K | -5% | -$106.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-09 | S | D | 5,159 | $20.62 | 91,953 | D | — | — | (F2) 7,000 shares held indirectly by the reporting person were inadvertently reported on prior Form 4 filings as direct holdings. The reporting person's holdings on this Form 4 have been adjusted accordingly. |